| Impact of new treatments for respiratory failure on outcome of infants with congenital diaphragmatic hernia. | |
| | |
MedLine Citation:
|
PMID: 10486074 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
CONCLUSION: Management based on early HFOV, eventually associated with surfactant, iNO and ECMO to achieve preoperative stabilisation, resulted in a good survival rate (89%) and good neurodevelopmental outcome at 1 year of age in infants with CDH. |
| | |
Authors:
|
M Somaschini; G Locatelli; L Salvoni; C Bellan; A Colombo |
Related Documents
:
|
3412844 - Reduced severity of oxygen-induced retinopathy in kittens recovered in 28% oxygen. 12841404 - Innovative neonatal ventilation and meconium aspiration syndrome. 11204714 - Effect of oxygen inhalation at birth on the reduction of early postnatal mortality in p... 15893334 - Intermittent exposure to reduced oxygen levels affects prey size selection and consumpt... 17330304 - Hydrocephalus and macrocephaly: new manifestations of neonatal lupus erythematosus. 19019594 - The neuroendocrine effects of the taser x26: a brief report. |
Publication Detail:
|
Type: Clinical Trial; Journal Article |
Journal Detail:
|
Title: European journal of pediatrics Volume: 158 ISSN: 0340-6199 ISO Abbreviation: Eur. J. Pediatr. Publication Date: 1999 Oct |
Date Detail:
|
Created Date: 1999-11-17 Completed Date: 1999-11-17 Revised Date: 2013-05-20 |
Medline Journal Info:
|
Nlm Unique ID: 7603873 Medline TA: Eur J Pediatr Country: GERMANY |
Other Details:
|
Languages: eng Pagination: 780-4 Citation Subset: IM |
Affiliation:
|
Divisione di Patologia Neonatale, Ospedali Riuniti, Largo Barozzi 1, I-24128 Bergamo, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Cattle Combined Modality Therapy Developmental Disabilities / etiology Extracorporeal Membrane Oxygenation Follow-Up Studies Gestational Age Hernia, Diaphragmatic / complications, congenital*, mortality High-Frequency Ventilation* Humans Infant Infant, Newborn Infant, Premature Infant, Premature, Diseases / mortality, therapy Nitric Oxide / therapeutic use Pulmonary Surfactants / therapeutic use Respiratory Insufficiency / etiology, mortality, therapy* Survival Rate |
| Chemical | |
Reg. No./Substance:
|
0/Pulmonary Surfactants; 10102-43-9/Nitric Oxide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Growth in childhood thyrotoxicosis.
Next Document: Toxic methaemoglobin concentrations in premature infants after application of a prilocaine-containin...